Medicinal Chemistry of Farnesoid X Receptor (FXR) Modulators: The-State-of-the-Art

被引：0
|
作者：
Marinozzi, Maura [1 ]
机构：
[1] Univ Perugia, Dept Pharmaceut Sci, I-06100 Perugia, Italy
来源：
CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2014年 / 14卷 / 19期
关键词：
D O I：
10.2174/1568026614666141112104841
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2127 / 2128
页数：2
相关论文
共 50 条
  • [31] Bile Diversion Improves Metabolic Phenotype Dependent on Farnesoid X Receptor (FXR)
    Pierre, Joseph F.
    Li, Yuxin
    Gomes, Charles K.
    Rao, Prahlad
    Chang, Eugene B.
    Yin, Deng Ping
    OBESITY, 2019, 27 (05) : 803 - 812
  • [32] On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity
    Kronenberger, Thales
    Windshugel, Bjorn
    Wrenger, Carsten
    Honorio, Kathia M.
    Maltarollo, Vinicius G.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (16): : 4378 - 4391
  • [33] Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists
    Zhu, Yuanju
    Zhang, Jay
    Min, Feng
    Yang, Xinying
    Li, Li
    Zhang, Yan
    Hou, Xuben
    Fang, Hao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 76
  • [34] Immunolocalization of farnesoid X receptor (FXR) in mouse tissues using tissue microarray
    Higashiyama, Hiroyuki
    Kinoshita, Mine
    Asano, Satoshi
    ACTA HISTOCHEMICA, 2008, 110 (01) : 86 - 93
  • [35] Farnesoid X receptor (FXR) as a novel target in vascular smooth muscle cells
    Bishop-Bailey, D
    Walsh, DT
    Warner, TD
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U30 - U30
  • [36] Conformationally constrained farnesoid X receptor (FXR) agonists: Alternative replacements of the stilbene
    Akwabi-Ameyaw, Adwoa
    Caravella, Justin A.
    Chen, Lihong
    Creech, Katrina L.
    Deaton, David N.
    Madauss, Kevin P.
    Marr, Harry B.
    Miller, Aaron B.
    Navas, Frank, III
    Parks, Derek J.
    Spearing, Paul K.
    Todd, Dan
    Williams, Shawn P.
    Wisely, Bruce
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (20) : 6154 - 6160
  • [37] Activation of Farnesoid X Receptor (FXR) Reduces Atherosclerosis in LDLRKO and apoEKO Mice
    Hartman, Helen B.
    Harnish, Douglas C.
    Evans, Mark J.
    CIRCULATION, 2008, 118 (18) : S566 - S566
  • [38] Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice
    Zhang, Xiaoyan
    Huang, Shizheng
    Gao, Min
    Liu, Jia
    Jia, Xiao
    Han, Qifei
    Zheng, Senfeng
    Miao, Yifei
    Li, Shuo
    Weng, Haoyu
    Xia, Xuan
    Du, Shengnan
    Wu, Wanfu
    Gustafsson, Jan-Ake
    Guan, Youfei
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (06) : 2277 - 2282
  • [39] Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene
    Bass, Jonathan Y.
    Caravella, Justin A.
    Chen, Lihong
    Creech, Katrina L.
    Deaton, David N.
    Madauss, Kevin P.
    Marr, Harry B.
    McFadyen, Robert B.
    Miller, Aaron B.
    Mills, Wendy Y.
    Navas, Frank, III
    Parks, Derek J.
    Smalley, Terrence L., Jr.
    Spearing, Paul K.
    Todd, Dan
    Williams, Shawn P.
    Wisely, G. Bruce
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (04) : 1206 - 1213
  • [40] The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis
    Cariou, B.
    DIABETES & METABOLISM, 2008, 34 (06) : 685 - 691
12345